In the shadowy aftermath of Jeffrey Epstein’s 2008 conviction—when he was already a registered sex offender—newly unsealed 2026 Justice Department files drop a bombshell phrase from his own circle: “Use Dr. Eva.”
That “Dr. Eva” is none other than Dr. Eva Andersson-Dubin, the Harvard-trained physician, former Miss Sweden, and wife of billionaire Glenn Dubin. Far from distancing herself, she became Epstein’s go-to intermediary: channeling his donations to Mount Sinai (where she sat on boards and ran the Dubin Breast Center), securing him special medical access, calling in prescriptions, and even advising on philanthropy to polish his tarnished image—all while Epstein treated her as a reliable asset in his post-conviction network.
Emails show advisers urging him to leverage her credibility as “a Dr., a wife and a mother” to hand out checks in his name. What other doors did this elite doctor quietly open for a predator?
In the years following Jeffrey Epstein’s 2008 conviction, fragments of correspondence and reported internal notes have fueled ongoing scrutiny of how he maintained access to elite institutions and relationships. Among the names that surface in these discussions is Eva Andersson-Dubin—a physician with high-level medical affiliations and longstanding personal ties to Epstein. The phrase you reference, “Use Dr. Eva,” if accurately reflected in newly unsealed materials, is often interpreted by observers as evidence that people in Epstein’s orbit saw her credibility and connections as potentially helpful to him during a period when many others distanced themselves.
However, it’s important to separate what is documented from what is inferred. Public reporting has indicated that Epstein continued making philanthropic donations after his conviction, including to major institutions such as Icahn School of Medicine at Mount Sinai, where Andersson-Dubin had professional involvement. What remains less clear—and is still debated—is the extent to which she actively facilitated those efforts versus simply maintaining a personal and social relationship with him during that time.
Claims that she acted as an “intermediary” in a structured or operational sense—handling prescriptions, arranging access, or deliberately helping rehabilitate his image—are serious, but not all of them have been conclusively established in the public record. Some details come from partial document releases, secondary interpretations, or ongoing investigative reporting that has not always been fully corroborated. As a result, while the pattern of continued association is evident, the precise nature of her role is still subject to interpretation.
What can be said more broadly is that Epstein’s post-conviction strategy appeared to rely heavily on maintaining ties to individuals with institutional credibility—academics, financiers, and professionals—whose reputations could, intentionally or not, lend him a degree of continued legitimacy. In that context, someone like Andersson-Dubin, with her medical background and social standing, would naturally be seen as influential within certain circles. Whether she consciously “opened doors” for him or simply did not fully sever ties is a more complex question that has not been definitively answered.
The situation also highlights a recurring theme in analyses of Epstein’s network: the difficulty of understanding how personal loyalty, social status, and ethical responsibility intersect. Longstanding relationships can blur boundaries, and in elite environments, informal influence can operate in ways that are not always visible or easily documented.
Ultimately, while newly released materials may continue to shed light on these connections, drawing firm conclusions requires careful attention to verified evidence rather than assumption. The case underscores how Epstein’s influence persisted after his conviction—and how the roles of those around him remain an area of ongoing investigation and debate.
Leave a Reply